476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19
Zhong, Tingting, Huang, Zhaoliang, Pang, Xinghua, Chen, Na, Kwek, Konyew, Wynne, Chris, Konpa, Adam, Jin, Xiaoping, Xia, Yu, Wang, Maxwell Zhongmin, Li, Baiyong
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC
Andre, Fabrice, Hamilton, Erika P., Loi, Sherene, Anders, Carey K., Schmid, Peter, Stroyakovskiy, Daniil, Villanueva, Rafael, Pedrini, Jose Luiz, Doval, Dinesh Chandra, Zurawski, Bogdan, Chen, Shin-Cheh, Boston, Sarice Renee, Konpa, Adam, Pierotti, Barbara, Fabbri, Giulia, Jhaveri, Komal L.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC)
Andre, Fabrice, Hamilton, Erika P., Loi, Sherene, Im, Seock-Ah, Sohn, Joohyuk, Tseng, Ling-Ming, Anders, Carey K., Schmid, Peter, Boston, Sarice, Darilay, Annie, Herbolsheimer, Pia Maarit, Konpa, Adam, Patel, Gargi, Yu, Tinghui, Wrona, Magdalena, Jhaveri, Komal L.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
NVTG-07 SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF TRASTUZUMAB DERUXTECAN (T-DXD) IN PATIENTS WITH HER2+ METASTATIC BREAST CANCER (MBC) AND ACTIVE BRAIN METASTASES (BMS) IN DESTINY-BREAST07 (DB-07)
Anders, Carey, Loi, Sherene, Hamilton, Erika, Jhaveri, Komal, Schmid, Peter, Gökmen, Erhan, Im, Seock-Ah, Karaçin, Cengiz, Barrios, Carlos, Park, Yeon Hee, Topaloğlu, Sernaz, Boston, Sarice, Konpa, Adam, Mondal, Shoubhik, André, Fabrice
Published in Neuro-oncology advances (02.08.2024)
Published in Neuro-oncology advances (02.08.2024)
Get full text
Journal Article
Abstract PD18-11: Dose-Expansion Study of Trastuzumab Deruxtecan as Monotherapy or Combined With Pertuzumab in Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer in DESTINY-Breast07 (DB-07)
Hamilton, Erika, Jhaveri, Komal, Loi, Sherene, Anders, Carey, Schmid, Peter, Penkov, Konstantin, Artamonova, Elena, Zhukova, Lyudmila, Stroyakovsky, Daniil L., Doval, Dinesh Chandra, Villanueva, Rafael, Michelini, Flavia, Chandarlapaty, Sarat, Wilson, Matt, Boston, Sarice R., Konpa, Adam, Mondal, Shoubhik, Andre, Fabrice
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article